Business · 13/07/2006
FDA Releases Guidance on Electronic Submissions for Biological Products
The Food and Drug Administration (FDA) has made available a document outlining recommendations for manufacturers of biological products to submit lot release protocols in electronic format to the Center for Biologics Evaluation and Research (CBER)
Original source language: Federal Register — Food and Drug AdministrationOpen original release →